Procurement Summary
Country : Brazil
Summary : Acquisition of Restricted Pe Medicines (Tranexamic Acid, Adenosine, Alpostadil and Others)
Deadline : 18 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 122246531
Document Ref. No. : 90094/2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Purchase of restricted PE medicines (tranexamic acid, adenosine, alpostadil and others)
UASG Code: 90159
Notice from: 07/07/2025 from 08:00 to 13:00 and from 14:00 to 17:59 hs
Proposal Delivery: From 07/07/2025 to 08:00
Tranexamic acid, dosage 50 mg/ml, pharmaceutical form injectable solution
Quantity: 600
Adenosine, dosage 3 mg/ml, indication injectable solution
Quantity: 200
Alpostadil, dosage 20 mcg, injectable indication
Quantity: 100
Ambroxol, Composition salt hydrochloride, concentration 3 mg/ml, pharmaceutical form syrup
Amount : 800
Amiodarona, dosage 50mg/ml, injectable indication
Quantity: 1500
Atenolol, dosage 25 mg
Quantity: 6000
Bisacodil, 5 mg dosage
Quantity: 3000
Caffeine, concentration 20 mg/ml, pharmaceutical form injectable solution
Quantity: 200
Potassium chloride, concentration 60 mg/ml, pharmaceutical form SYRUP
Quantity: 200
Sodium Dantrolene, 20 mg concentration, injectable presentation, additional feature kit w/ 12frs lyophilized powder + 12frs w/ diluent
Quantity: 24
Epinephrine, dosage 1mg/ml, use injectable solution
Quantity: 5000
METILERGOMETRINA MALEATO, DOSAGE 0.2 mg/ML, INDICATION Injectable solution
Quantity: 200
Scopolamine butylbrometo, dosage 10 mg
Quantity: 3000
Esmolol Hydrochloride, dosage 250 mg/ml, injectable indication
Quantity: 10
Fluorescein, 1%concentration, application ophthalmic solution
Quantity: 15
Glucose, 25%concentration, indication injectable solution
Amount : 2000
Calcium glycinate, 10%dosage, presentation injectable solution
Quantity: 2000
Hydralazine, dosage 20 mg/ml, indication injectable solution
Quantity: 400
Iron III, concentration 10 mg/ml, pharmaceutical form syrup
Quantity: 300
Human immunoglobulin, 5 g concentration, pharmaceutical form Po Liofilo p ...
Documents
Tender Notice